These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19630487)

  • 1. Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention.
    Feldmann RE; Kranz G; Praschak-Rieder N; Kasper S
    Curr Med Res Opin; 2009 Sep; 25(9):2281-5. PubMed ID: 19630487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychopharmacotherapy of anxiety, obsessive-compulsive and sleep disorders during pregnancy and lactation].
    Szajer K; Karakuła H; Pawezka J; Grzywa A; Przywara G; Gut A
    Psychiatr Pol; 2005; 39(3):519-26. PubMed ID: 16149761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on psychotropic drugs for the EC. Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder.
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):151-5. PubMed ID: 7549458
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.
    J Clin Psychiatry; 1997; 58 Suppl 4():2-72. PubMed ID: 9183300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination of several psychotherapeutic methods including psychopharmaceuticals. A case of obsessive-compulsive disorder].
    Irgens A
    Tidsskr Nor Laegeforen; 1997 Apr; 117(9):1314-5. PubMed ID: 9182364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic and clinical findings of significance to the design of neuropharmacologic studies of obsessive-compulsive disorder.
    Rasmussen SA; Tsuang MT
    Psychopharmacol Bull; 1986; 22(3):723-9. PubMed ID: 3797577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Obsessive-compulsive neurosis explored using positron emission tomography. Apropos of a case].
    Des Lauriers AG; Martinot JL; Allilaire JF
    Ann Med Interne (Paris); 1989; 140(7):575-8. PubMed ID: 2692489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged therapy with endovenous chlorimipramine in dysphoric anxiety in obsessive neuroses].
    Fontanari D; Fassetta G
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Oct; 95(5):938-41. PubMed ID: 5159723
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of psychopharmacology in obsessive compulsive disorders.
    Sarwer-Foner GJ
    Psychiatr J Univ Ott; 1987 Nov; 12(4):197-202. PubMed ID: 3326003
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychocutaneous drug therapy.
    Lee CS; Koo J
    Semin Cutan Med Surg; 2003 Sep; 22(3):222-33. PubMed ID: 14649589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychostimulants: a therapeutic alternative in thymic and obsessive compulsive disorders (second part)].
    Samain V
    Rev Med Brux; 2004 Feb; 25(1):29-39. PubMed ID: 15053152
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stereotaxic cingulotomy in the complex treatment of a schizophrenic patient with obsessive-compulsive disorder, resistant to treatment].
    Shustin VA; Korzenev AV; Gorskiĭ GD; Vovin RIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):92-5. PubMed ID: 1654718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic agents in dermatology.
    Koo JY
    Dermatol Clin; 1993 Jan; 11(1):215-24. PubMed ID: 8435914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychostimulants: a potential therapeutic alternative in mood and obsessive compulsive disorders (first part)].
    Samain V
    Rev Med Brux; 2003 Dec; 24(6):464-9. PubMed ID: 14748179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meprobamate overdosage: a continuing problem.
    Allen MD; Greenblatt DJ; Noel BJ
    Clin Toxicol; 1977 Dec; 11(5):501-15. PubMed ID: 608316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and maintenance electroconvulsive therapy for treatment of severely disabling obsessive-compulsive symptoms in a patient with Asperger syndrome.
    Nilsson BM; Ekselius L
    J ECT; 2009 Sep; 25(3):205-7. PubMed ID: 19384252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy in neuroacanthocytosis or McLeod syndrome.
    Vázquez MJ; Martínez MC
    J ECT; 2009 Mar; 25(1):72-3. PubMed ID: 18997633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to medication during psychoanalysis.
    Roose SP; Gabbard GO
    J Psychother Pract Res; 1997; 6(3):239-48. PubMed ID: 9185069
    [No Abstract]   [Full Text] [Related]  

  • 19. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
    Pasquini M; Berardelli I
    Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology in psychodermatology.
    Shukla R; Sasseville D
    J Cutan Med Surg; 2008; 12(6):255-67. PubMed ID: 19317947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.